4 Einträge gefunden

1. Anti-CD38 antibody therapy for patients with relapsed/refractory multiple myeloma: differential mechanisms of action and recent clinical trial outcomes

   1. Leleu, Xavier
   2. Martin, Thomas
   3. Weisel, Katja
   4. Schjesvold, Fredrik
   5. Iida, Shinsuke
   6. Malavasi, Fabio
   7. Manier, Salomon

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
2. Pomalidomide, bortezomib, and dexamethasone at first relapse in lenalidomide-pretreated myeloma: a subanalysis of OPTIMISMM by clinical characteristics

   1. Richardson, Paul G
   2. Schjesvold, Fredrik
   3. Weisel, Katja
   4. Moreau, Philippe
   5. Anderson, Larry D
   6. White, Darrell
   7. Rodriguez-Otero, Paula

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
3. Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group

   1. Moreau, Philippe
   2. Kumar, Shaji K
   3. San Miguel, Jesús
   4. Davies, Faith
   5. Zamagni, Elena
   6. Bahlis, Nizar
   7. Ludwig, Heinz

   2021 - Forschungsinformationssystem des UKE
4. Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial

   1. Richardson, Paul G
   2. Oriol, Albert
   3. Beksac, Meral
   4. Liberati, Anna Marina
   5. Galli, Monica
   6. Schjesvold, Fredrik
   7. Lindsay, Jindriska

   2019 - Forschungsinformationssystem des UKE